Cohen Klingenstein’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.9M Sell
151,669
-2,130
-1% -$193K 0.37% 36
2026
Q2
$14.1M Sell
153,799
-12,400
-7% -$1.08M 0.4% 35
2026
Q1
$14.2M Sell
166,199
-1,950
-1% -$174K 0.46% 33
2025
Q4
$13.3M Hold
168,149
– – 0.4% 32
2025
Q3
$13.4M Hold
168,149
– – 0.42% 32
2025
Q2
$15.3M Hold
168,149
– – 0.51% 27
2025
Q1
$15.8M Sell
168,149
-8,000
-5% -$716K 0.57% 26
2024
Q4
$16M Sell
176,149
-4,000
-2% -$382K 0.55% 27
2024
Q3
$18.7M Sell
180,149
-219
-0.1% -$22.3K 0.65% 25
2024
Q2
$17.5M Hold
180,368
– – 0.64% 24
2024
Q1
$16.2M Hold
180,368
– – 0.6% 29
2023
Q4
$14.4M Hold
180,368
– – 0.59% 33
2023
Q3
$12.8M Sell
180,368
-199
-0.1% -$14.9K 0.58% 32
2023
Q2
$13.9M Sell
180,567
-2,368
-1% -$183K 0.6% 31
2023
Q1
$13.7M Sell
182,935
-2,665
-1% -$198K 0.65% 31
2022
Q4
$14.6M Hold
185,600
– – 0.74% 28
2022
Q3
$13M Hold
185,600
– – 0.69% 26
2022
Q2
$14.9M Hold
185,600
– – 0.75% 23
2022
Q1
$14.1M Hold
185,600
– – 0.58% 30
2021
Q4
$15.8M Sell
185,600
-4,000
-2% -$312K 0.63% 29
2021
Q3
$14.3M Sell
189,600
-15,600
-8% -$1.24M 0.63% 31
2021
Q2
$16.7M Hold
205,200
– – 0.72% 30
2021
Q1
$16.2M Hold
205,200
– – 0.75% 30
2020
Q4
$17.5M Hold
205,200
– – 0.88% 27
2020
Q3
$15.8M Hold
205,200
– – 0.89% 27
2020
Q2
$15M Hold
205,200
– – 0.92% 26
2020
Q1
$13.6M Hold
205,200
– – 1.01% 23
2019
Q4
$14.1M Hold
205,200
– – 0.82% 31
2019
Q3
$15.1M Buy
205,200
+12,800
+7% +$929K 0.95% 26
2019
Q2
$13.8M Sell
192,400
-12,800
-6% -$909K 0.98% 23
2019
Q1
$14.1M Buy
205,200
+170,600
+493% +$11M 0.98% 23
2018
Q4
$2.06M Hold
34,600
– – 0.31% 58
2018
Q3
$2.32M Hold
34,600
– – 0.29% 58
2018
Q2
$2.24M Hold
34,600
– – 0.31% 57
2018
Q1
$2.48M Hold
34,600
– – 0.35% 54
2017
Q4
$2.61M Hold
34,600
– – 0.37% 54
2017
Q3
$2.52M Hold
34,600
– – 0.38% 55
2017
Q2
$2.56M Hold
34,600
– – 0.4% 51
2017
Q1
$2.53M Hold
34,600
– – 0.41% 48
2016
Q4
$2.26M Hold
34,600
– – 0.39% 53
2016
Q3
$2.56M Hold
34,600
– – 0.45% 40
2016
Q2
$2.53M Hold
34,600
– – 0.47% 36
2016
Q1
$2.44M Hold
34,600
– – 0.46% 38
2015
Q4
$2.3M Hold
34,600
– – 0.43% 35
2015
Q3
$2.2M Hold
34,600
– – 0.43% 36
2015
Q2
$2.26M Hold
34,600
– – 0.41% 38
2015
Q1
$2.4M Hold
34,600
– – 0.44% 39
2014
Q4
$2.39M Hold
34,600
– – 0.45% 39
2014
Q3
$2.26M Hold
34,600
– – 0.4% 39
2014
Q2
$2.36M Hold
34,600
– – 0.45% 36
2014
Q1
$2.24M Hold
34,600
– – 0.45% 37
2013
Q4
$2.26M Hold
34,600
– – 0.45% 37
2013
Q3
$2.05M Hold
34,600
– – 0.45% 36
2013
Q2
$1.98M Buy
+34,600
New +$2.05M 0.46% 36

Other funds holding CL

Cohen Klingenstein's CL Position: Q3 2026 in Review

Cohen Klingenstein reduced its Colgate-Palmolive (CL) stake by 1.4% in Q3 2026, selling an estimated $193K and leaving 151,669 shares worth $12.9M. The position accounts for 0.37% of the portfolio, ranked #36.

Cohen Klingenstein first reported a position in CL in Q2 2013 and has held it in 54 quarters since. The position peaked at $18.7M in Q3 2024. 786 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Cohen Klingenstein held 151,669 shares of Colgate-Palmolive worth $12.9M as of Q3 2026.
  • Cohen Klingenstein sold 2,130 Colgate-Palmolive shares in Q3 2026, an estimated $193K.
  • Colgate-Palmolive made up 0.37% of Cohen Klingenstein's portfolio in Q3 2026, its #36 holding.
  • Cohen Klingenstein first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 54 quarters since.
  • Cohen Klingenstein's Colgate-Palmolive position peaked at $18.7M in Q3 2024.
  • 786 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Cohen Klingenstein's 13F filing for Q3 2026, filed 15 Oct 2026.